Subscribe To
OCUP / Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
OCUP News
By Market Watch
September 27, 2023
Viatris and Ocuphire Pharma get FDA green light for eye treatment
Viatris Inc. VTRS, and Ocuphire Pharma Inc. OCUP, +3.08% said Wednesday that the U.S. Food and Drug Administration has approved Ryzumvi to treat the s more_horizontal
By Benzinga
April 21, 2023
Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case - Ocuphire Pharma (NASDAQ:OCUP)
Ocuphire Pharma Inc OCUP was plunging over 22% at one point on Friday after the company announced it appointed Rick Rodgers to the role of interim CE more_horizontal
By Zacks Investment Research
April 21, 2023
Wall Street Analysts Believe Ocuphire Pharma, Inc. (OCUP) Could Rally 257.14%: Here's is How to Trade
The consensus price target hints at a 257.1% upside potential for Ocuphire Pharma, Inc. (OCUP). While empirical research shows that this sought-after more_horizontal
By Zacks Investment Research
April 21, 2023
Ocuphire Pharma, Inc. (OCUP) Is a Great Choice for 'Trend' Investors, Here's Why
Ocuphire Pharma, Inc. (OCUP) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit fro more_horizontal
By Zacks Investment Research
April 5, 2023
Does Ocuphire Pharma, Inc. (OCUP) Have the Potential to Rally 323.89% as Wall Street Analysts Expect?
The mean of analysts' price targets for Ocuphire Pharma, Inc. (OCUP) points to a 323.9% upside in the stock. While this highly sought-after metric has more_horizontal
By Zacks Investment Research
April 5, 2023
Here's Why Momentum in Ocuphire Pharma, Inc. (OCUP) Should Keep going
Ocuphire Pharma, Inc. (OCUP) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound more_horizontal
By InvestorPlace
January 26, 2023
Why Is Ocuphire Pharma (OCUP) Stock Down 20% Today?
Ocuphire Pharma (NASDAQ: OCUP ) stock is falling on Thursday after the company posted results from a Phase 2 clinical trial. The clinical trial evalua more_horizontal
By GlobeNewsWire
April 6, 2022
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
FARMINGTON HILLS, Mich., April 06, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical compan more_horizontal